RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Novel Design Changes in DES Not Necessarily Better until Proven So
JF MD Conference Express
YR 2012
FD SAGE Publications
VO 12
IS 8
SP 24
OP 24
DO 10.1177/155989771208012
UL http://mdc.sagepub.com/content/12/8/24.abstract
AB A drug-eluting stent is a “combination product” in which changes to one component may affect others; small alterations to strut thickness and geometry, polymer, drug, dose, and kinetics may result in big outcome changes, for better or worse. This article discusses the many factors involved in the development and deployment of novel stents.